mTPE Device Market: Information by Therapeutic Type (Bone Marrow, Renal Dialysis), Application (Cell Depletion, Granulocyte Collection), and End User, and Region — Forecast till 2029

Therapeutic plasma exchange (mTPE) removes and replaces a patient’s blood plasma and can treat several autoimmune diseases. The antibodies in autoimmune diseases are known for attacking specific parts of the body and cause a spectrum of symptoms, depending on the target.

The process starts with the removal of plasma, which is then pumped through a large-pore membrane of the plasma filter. The growing prevalence of such autoimmune diseases is subsequently boosting the market growth, which is further grabbing the attention of several emerging players in the therapeutic plasma exchange (mTPE) device market. For instance, recently, Baxter—a pioneer and a single leader in the industry—introduced ‘PRISMAFLEX System,’ a flexible, filter-based solution that meets the demand of multiple therapies. The device is backed with a number of features including, accurate fluid management, streamlined alarm management, patented deaeration chamber, and innovative sterile solution. It is specially designed for providing healthcare professionals with more efficacy in the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies. Apart from this, supportive government regulations for reimbursement policies regarding healthcare and rising consolidation for healthcare amenities are adding fuel to the market growth.

Factors Driving the mTPE Device Market

The rising prevalence of chronic diseases and intensive research and clinical trials are the factors contributing to the market growth. The players in the mTPE device market are arduously working to provide user-friendly devices with consolidated safety and low maintenance cost to patients across the globe. For the record, the mTPE device decreases the maintenance cost by choosing a membrane that complies with the individual patient requirements, which is further boosting the market growth.

Request For Sample Report : https://straitsresearch.com/report/mtpe-device-market/request-sample

Baxter to Lead the Overall Market

In the mTPE device market, Baxtermanufactures highly specialized filtering blood purification therapies and ensures utmost patient safety. For nurses and clinicians, the ‘PRISMAFLEX System’ helps to save time by providing automatic adjustments allied with immediate visual feedback of the system’s status.

Market Segmentation of Global mTPE Device Market

The key segments of the mTPE device market the therapeutic application, therapeutic types, and end-user.

By therapeutic application, the mTPE device market is segmented into plasma or red cell exchange, cell depletion, granulocyte collection, and stem cell collection. The stem cell collection segment is dominating the market and will continue the same during the forecast period.

On the basis of therapeutic type, the mTPE device market is segmented into hemophilia, bone marrow, platelet transfusion, and renal dialysis. The platelet transfusion is projected to capture a major market share with the highest CAGR.

By end-user, the mTPE device market is segmented into hospitals, research laboratories, blood banks, and blood transfusion laboratories. The hospital segment is leading the mTPE device market on account of increasing patient pool, rising prevalence of several diseases, and shifting preference towards technologically advanced medical treatments. The research laboratories segment is projected to increase at a significant pace during the forecast period.

Regional Insights

North America is holding one of the largest shares in the global mTPE device market. The region is backed by the presence of leading industry players, increasing patient pool, and rising population. Moreover, rapid expansion and a surge in the number of research and academic institutions in the region are boosting the market growth. In addition, the Institutional Ethical Committee and Medical Research Councils are two such prominent research institutes in the market. Other factors driving the market growth include the rising prevalence of neurological diseases, increasing clinical response rate for therapeutic plasma exchange for the treatment of Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and myasthenia gravis, and growing prevalence of multiple sclerosis.

Europe is second in the global mTPE device market and will continue the same during the forecast period. This can be attributed to the well-equipped healthcare infrastructure, advanced medical technologies, and a high population base. The region is likely to emboss an impressive footprint in the overall mTPE device market in the years to come.

Asia Pacific is the fastest growing mTPE device market on account of raising awareness of diagnosis among the patients, rising expenditure power, government support, rising investments by leading players, and the presence of major players. The key markets gaining high profitability index include Japan, China, Australia, Singapore, and New Zealand. In the region, China is dominating the mTPE device market; whereas, India is expected to witness significant growth during the forecast period.

Furthermore, LAMEA is projected to witness steady growth during the forecast period.

Competitive Landscape

Global mTPE device market has the presence of established players that are acquiring emerging players for expanding their portfolio and increasing their market share. Baxter is one of the major companies functional in the mTPE device market. It offers a wide range of product pipelines with continuous advancements and up-gradations to sustain in the cut-throat competition.

In 2013, Baxter acquired Gambro to expand its therapeutic product portfolio and geographical reach. Apart from this, raising awareness among the patients and physicians concerning the company’s products is further boosting the company's growth.

Key Takeaway

On 11th February 2019:NantHealth and Baxter International Inc. announced that NantHealth digital Health Solution is now available to connect Baxter’s ‘Prismaflex system’ to a hospital Electronic Medical Record (EMR).Prismaflex is extensively used for treating patients in ICU with acute kidney injury (AKI) and certain life-threatening blood and autoimmune conditions.

Our Report Covers

Historical inferences, findings & analysis of the market from 2016–2018
Projections and performance forecast analysis for the future from 2019–2026
Production and consumption point of view (POV) analysis
Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, and technological & pricing trends
Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

Buy Now : https://straitsresearch.com/buy-now/mtpe-device-market/global/

mTPE Device Market: Segmentation

By Therapeutic Application

Plasma or red cell exchange
Cell depletion
Granulocyte collection
Stem cell collection
By Therapeutic Type

Hemophilia
Bone marrow
Platelet transfusion
Renal dialysis
By End-User

Hospitals
Research Laboratories
Blood bank
Blood transfusion laboratories
By Region

Americas

North America
S.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe

Western Europe
K
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific

China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
MEA

The Middle East
Saudi Arabia
UAE
Qatar
Rest of the Middle East
Africa

Contact Us:
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846
Website: https://straitsresearch.com/

About Us :
StraitsResearch.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

This release was published on openPR.